Dáil Éireann Debate, Tuesday - 2 October 2018
325. Deputy Michael Healy-Rae asked the Minister for Health the reason the HSE is not paying a person (details supplied) for the treatment abroad scheme; and if he will make a statement on the matter. [39417/18]
View answerThe HSE operates two schemes which facilitate patients accessing treatments abroad. The first is the Treatment Abroad Scheme (TAS) which applies where the treatment is not available in the Irish public hospital system.
The second is under the Cross Border Directive (CBD). Under the terms of the Directive, patients of an EU/EEA Member State who meet the necessary criteria may opt to avail of healthcare provided under the legislation of their Member State of affiliation in another EU/EEA Member State and be reimbursed the lesser of the cost of receiving the treatment abroad, or the cost in their own Member State.
The HSE have confirmed that they have not received an application from Mr Poslada in respect of either the TAS or CBD.
On the basis of the information given, Mr Poslada was not eligible for the TAS as the treatment did not meet the criteria for that scheme, one of which is that the treatment is not available in the patient's member state.
If Mr Poslada would like to contact HSE National Contact Point office they will advise him on how to make an application under the CBD, which the HSE will then assess. The contact details are: National Contact Point: HSE Cross Border Directive, St Canice's Hospital, Dublin Road, Kilkenny. Tel: 056 778 4547 or 056 778 4546 or 056 778 4556. email:
crossborderdirective@hse.ie.
